Systemic Lupus Erythematosus with Lupus Nephritis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2006-10-13
EMA Application withdrawn: Riquent (abetimus) — La Jolla Limited
The EMA withdrew the application for Riquent (abetimus) by La Jolla Limited for lupus nephritis.